Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the European Patent Office has issued a new patent, No. 3352584, to the company’s TriLink BioTechnologies subsidiary. The patent relates […]
Unique approach harnesses Evonetix’s thermally-controlled DNA-on-chip technology to simplify writing, accessing and reading stored DNA Demonstrates potential application of Evonetix’s technology beyond gene synthesis Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has been granted patent GB 2576304 for its […]
BIRMINGHAM, Ala. — TriAltus Bioscience announced that the U.S Patent and Trademark Office has issued U.S. Patent No 10,759,830 for its CLīM affinity tag system, which delivers proteins with ultra-high purity and yield in a single step. The patent, entitled “Bacterial colicin-immunity protein purification system,” covers mutations made to colicin E7, a naturally occurring e.coli protein, […]
UK Intellectual Patent Office (UK IPO) has granted RevoluGen’s third patent covering its spin-based Fire Monkey High Molecular Weight (HMW) DNA extraction/size selection technology RevoluGen now owns controlling IP covering novel chemistry, column matrix and elution method Fire Monkey HMW-DNA Extraction/Size Selection produces library-ready homogenous, long-length DNA (average appx. 100kb +) for short- and long-read […]
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The agreement resolves all outstanding litigation and other proceedings between the two companies across […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that it has […]
The integration of the sequence of each single cell coupled with IsoPlexis’ proprietary functional proteomics accelerates insights into discovery biology & development of advanced medicines BRANFORD, Conn. — IsoPlexis, the leader in functional single-cell proteomics, today announced the acquisition of an extensive intellectual property portfolio of 86 patents related to DNA and RNA sequencing. These nucleic […]
Today the Court of Appeals for the Federal Circuit issued a unanimous Precedential Opinion and Judgment affirming the jury’s March 2020 verdict in the PacBio v. Oxford Nanopore case, that invalidated a number of PacBio patents. This has been a long running dispute in which Oxford Nanopore has repeatedly prevailed. In 2018, Oxford Nanopore was […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), announced that the United States Patent and Trademark Office will issue US Patent No. 10,995,364 today, May 4, 2021. The patent, titled “METHODS AND DEVICES FOR SINGLE-MOLECULE WHOLE GENOME ANALYSIS” covers methods for labeling DNA molecules with one or more sequence-specific probes and detecting the signal from […]
The European Commission has fined Sigma-Aldrich €7.5 million for providing incorrect or misleading information during the Commission’s investigation under the EU Merger Regulation of Merck’s acquisition of Sigma-Aldrich. Executive Vice-President Margrethe Vestager, in charge of competition policy, said: “The effectiveness of our merger control system relies on the accuracy of the information provided by the companies involved. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
